Abstract
It was January 20, 2015. Sitting in his office situated in the lush green campus of National Chemical Laboratory (NCL), a constituent R&D laboratory of the Council for Scientific and Industrial Research (CSIR) India, Pune, Amitabh Shrivastava, CEO and Executive Director, CSIR-Tech Private Limited (CTPL), looked at the presentation he had made to the representatives from development institutions, banks, Indian arm of global MNCs, and corporates for raising a venture fund to invest in Indian scientific start-ups. His efforts had led to the formation of a corpus of INR 50 croresa, known as the India Science Venture Fund (ISVF) to help in the creation of spin-offs in areas of science and technology by providing seed money and start-up grants.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
